| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Cullinan Therapeutics, Inc. (CGEM) have been net sellers, shedding 38,000 shares worth roughly $780K on balance.
CGEM sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 390.8K | $5.65M | - | |
| Other | 160.0K | $2.31M | - | |
| Other | 158.8K | $3.43M | - | |
| Other | 130.6K | $1.12M | - | |
| CFO | 127.9K | $1.10M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 18, 2025 | Sumer Jacquelyn L | Chief Legal Officer | Sell | 3,480 | $9.67 | $33,651.60 | -2.5% | +31.6% | - | |
| Dec 18, 2025 | Michaelson Jennifer65 | Chief Scientific Officer | Sell | 2,898 | $9.67 | $28,023.66 | -2.1% | +31.6% | - | |
| Dec 15, 2025 | Michaelson Jennifer65 | Chief Scientific Officer | Sell10b5-1 | 3,143 | $12.23 | $38,432.74 | -2.2% | +29.7% | - | |
| Nov 24, 2025 | Michaelson Jennifer65 | Chief Scientific Officer | Sell10b5-1 | 4,000 | $12.30 | $49,200.00 | -2.8% | +8.2% | - | |
| Oct 28, 2025 | Lynx1 Capital Management LP47 | 10% Owner | Buy | 165,667 | $8.40 | $1,391,685.63 | +1.9% | +41.0% | +69.3% | |
| Oct 17, 2025 | Lynx1 Capital Management LP47 | 10% Owner | Buy | 248,749 | $8.46 | $2,103,912.01 | +2.9% | +35.7% | +64.6% | |
| Oct 10, 2025 | Lynx1 Capital Management LP47 | 10% Owner | Buy | 1,459,641 | $6.73 | $9,826,941.41 | +20.6% | +50.5% | +109.9% | |
| Feb 25, 2025 | Jones Jeffrey Alan | Chief Medical Officer | Sell | 4,895 | $8.53 | $41,754.35 | -2.7% | -8.6% | +67.8% | |
| Feb 25, 2025 | Michaelson Jennifer65 | Chief Scientific Officer | Sell | 3,756 | $8.53 | $32,038.68 | -2.6% | -8.6% | +67.8% | |
| Feb 25, 2025 | Ahmed Nadim49 | President and CEO | Sell | 12,529 | $8.53 | $106,872.37 | -2.8% | -8.6% | +67.8% |